# FDA Inspection 1167305 - CordenPharma Brussels SA - January 31, 2020

Source: https://www.keypedia.com/records/fda_inspections/cordenpharma-brussels-sa/87685eed-3921-40ba-8353-99b4c24cfdb2
Source feed: FDA_Inspections

> FDA Inspection 1167305 for CordenPharma Brussels SA on January 31, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167305
- Company Name: CordenPharma Brussels SA
- Inspection Date: 2020-01-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1005031 - 2017-02-03](https://www.keypedia.com/records/fda_inspections/cordenpharma-brussels-sa/440f5678-e355-4991-98c0-7db346dc57b2)
- [FDA Inspection 917907 - 2015-02-27](https://www.keypedia.com/records/fda_inspections/cordenpharma-brussels-sa/bf891c64-7417-479b-8734-48f0a1800325)
- [FDA Inspection 819585 - 2013-01-30](https://www.keypedia.com/records/fda_inspections/cordenpharma-brussels-sa/4ee1433c-655f-4781-a27f-fe34c9a024ae)
- [FDA Inspection 584458 - 2009-04-02](https://www.keypedia.com/records/fda_inspections/cordenpharma-brussels-sa/3d120562-e3a1-473e-869d-e21b17f1b081)

Company: https://www.keypedia.com/companies/cordenpharma-brussels-sa/2f748258-ca7e-4e98-ba82-824fe80fdd75

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c